World Health Organization recommends GLP-1s amid obesity crisis
Mrinalika Roy | ReutersTrump announces lower prices coming for GLP-1 drugs Zepbound, WegovyPresident Donald Trump announces discounted pricing for Zepbound...
Obesity
WHO backs wider use of weight-loss medicines, calling obesity a chronic disease
The guidance focuses on GLP-1 therapies – medicines such as liraglutide, semaglutide and tirzepatide – and offers conditional recommendations on...
WHO conditionally recommends GLP-1 drugs for obesity
Listen to this articleEstimated 3 minutesThe audio version of this article is generated by text-to-speech, a technology based on artificial...
WHO issues global guideline on the use of GLP-1 medicines in treating obesity
To address the growing global health challenge of obesity, which affects more than 1 billion people, the World Health Organization (WHO)...
Obesity and overweight
Key factsIn 2022, 1 in 8 people in the world were living with obesity. Worldwide adult obesity has more than...
